New Mountain Capital-Backed MSD Sold to McKesson

We served as co-counsel with Simpson Thacher & Bartlett LLP in the sale of Medical Specialties Distributors (MSD) to McKesson Corporation (Nasdaq: MCK) for $800 million. The deal is part of the continuing effort by McKesson management to respond to changes in healthcare supply and device distribution.

Medical Specialty Distributors (MSD) is a leading post-acute/non-hospital patient supply chain provider offering a broad portfolio of medical supplies, biomedical services, and technology solutions.

New Mountain Capital is a New York based investment firm that emphasizes business building and non-cyclical growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $20 billion in aggregate capital commitments.

You Also May Be Interested In:

  • Representing the independent Special Committee of Strategic Storage Growth Trust, Inc. (SSGT), in its definitive agreement to merge with Strategic Storage Trust II, Inc., (SST II) in an all-cash merger valued at $340 million expected to close during the first quarter of 2019, subject to customary closing conditions, including the approval of SSGT’s stockholders

    We are representing the independent Special Committee of Strategic Storage Growth Trust, Inc. (SSGT), in its definitive agreement to merge...
    Client Type: Private Company
  • Represented Wright Medical Group in its acquisition of Cartiva, Inc.

    We served as lead counsel to Wright Medical Group N.V. (Nasdaq: WMGI) in the acquisition of Cartiva, Inc., a privately-held...
    Client Type: Public Company
  • We represented NN, Inc. (Nasdaq: NNBR) in its public offering of 14,375,000 shares of common stock, which was composed of...
    Client Type: Public Company